Bank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective upped by Bank of America from $22.00 to $26.00 in a report issued on Tuesday morning,Benzinga reports. Bank of America currently has an underperform rating on the stock. A number of other equities research analysts also recently weighed in on HIMS. TD Cowen […]

Leave a Reply

Your email address will not be published.

Previous post Advanced Energy Industries (NASDAQ:AEIS) Shares Gap Up Following Better-Than-Expected Earnings
Next post Editas Medicine (NASDAQ:EDIT) Raised to Strong-Buy at Cantor Fitzgerald